Epidemiology and updated management for autoimmune liver disease

Affiliations

¹ Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
² Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Nae-Yun Heo et al. Clin Mol Hepatol. 2023 Jan.

. 2023 Jan;29(1):194-196.

doi: 10.3350/cmh.2022.0387. Epub 2022 Dec 14.

¹ Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
² Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

No abstract available

Keywords: Biliary; Cholangitis; Hepatitis; autoimmune; Liver cirrhosis; sclerosing.

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

1. Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol. 2021;27:58–69. - PMC - PubMed
1. Lv T, Li M, Zeng N, Zhang J, Li S, Chen S, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol. 2019;34:1676–1684. - PubMed
1. Kim BH, Choi HY, Ki M, Kim KA, Jang ES, Jeong SH. Populationbased prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea. PLoS One. 2017;12:e0182391. - PMC - PubMed
1. Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, et al. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis. J Hepatol. 2015;62:642–646. - PubMed
1. Ichai P, Duclos-Vallée JC, Guettier C, Hamida SB, Antonini T, Delvart V, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl. 2007;13:996–1003. - PubMed